Loading...

IM Cannabis Corp.

IMCC.CNCNQ
Healthcare
Drug Manufacturers - Specialty & Generic
$5.10
$-3.40(-40.00%)
Canadian Market opens in 7h 25m

IM Cannabis Corp. Fundamental Analysis

IM Cannabis Corp. (IMCC.CN) shows moderate financial fundamentals with a PE ratio of -14.53, profit margin of -2.97%, and ROE of -24.38%. The company generates $0.0B in annual revenue with strong year-over-year growth of 10.71%.

Key Strengths

PEG Ratio-0.24

Areas of Concern

ROE-24.38%
Operating Margin-51.59%
Cash Position4.77%
Current Ratio0.72
We analyze IMCC.CN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -12.4/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-12.4/100

We analyze IMCC.CN's fundamental strength across five key dimensions:

Efficiency Score

Weak

IMCC.CN struggles to generate sufficient returns from assets.

ROA > 10%
-2.79%

Valuation Score

Excellent

IMCC.CN trades at attractive valuation levels.

PE < 25
-14.53
PEG Ratio < 2
-0.24

Growth Score

Moderate

IMCC.CN shows steady but slowing expansion.

Revenue Growth > 5%
10.71%
EPS Growth > 10%
-1.35%

Financial Health Score

Weak

IMCC.CN carries high financial risk with limited liquidity.

Debt/Equity < 1
4.44
Current Ratio > 1
0.72

Profitability Score

Weak

IMCC.CN struggles to sustain strong margins.

ROE > 15%
-2438.07%
Net Margin ≥ 15%
-2.97%
Positive Free Cash Flow
No

Key Financial Metrics

Is IMCC.CN Expensive or Cheap?

P/E Ratio

IMCC.CN trades at -14.53 times earnings. This suggests potential undervaluation.

-14.53

PEG Ratio

When adjusting for growth, IMCC.CN's PEG of -0.24 indicates potential undervaluation.

-0.24

Price to Book

The market values IM Cannabis Corp. at 4.72 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

4.72

EV/EBITDA

Enterprise value stands at -5.82 times EBITDA. This is generally considered low.

-5.82

How Well Does IMCC.CN Make Money?

Net Profit Margin

For every $100 in sales, IM Cannabis Corp. keeps $-2.97 as profit after all expenses.

-2.97%

Operating Margin

Core operations generate -51.59 in profit for every $100 in revenue, before interest and taxes.

-51.59%

ROE

Management delivers $-24.38 in profit for every $100 of shareholder equity.

-24.38%

ROA

IM Cannabis Corp. generates $-2.79 in profit for every $100 in assets, demonstrating efficient asset deployment.

-2.79%

Following the Money - Real Cash Generation

Operating Cash Flow

IM Cannabis Corp. generates limited operating cash flow of $-216.82K, signaling weaker underlying cash strength.

$-216.82K

Free Cash Flow

IM Cannabis Corp. generates weak or negative free cash flow of $-251.93K, restricting financial flexibility.

$-251.93K

FCF Per Share

Each share generates $-0.07 in free cash annually.

$-0.07

FCF Yield

IMCC.CN converts -1.42% of its market value into free cash.

-1.42%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-14.53

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.24

vs 25 benchmark

P/B Ratio

Price to book value ratio

4.72

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.45

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

4.44

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.72

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.24

vs 25 benchmark

ROA

Return on assets percentage

-0.03

vs 25 benchmark

ROCE

Return on capital employed

-3.36

vs 25 benchmark

How IMCC.CN Stacks Against Its Sector Peers

MetricIMCC.CN ValueSector AveragePerformance
P/E Ratio-14.5329.04 Better (Cheaper)
ROE-24.38%712.00% Weak
Net Margin-2.97%-44581.00% (disorted) Weak
Debt/Equity4.440.34 Weak (High Leverage)
Current Ratio0.724.53 Weak Liquidity
ROA-2.79%-18069.00% (disorted) Weak

IMCC.CN outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews IM Cannabis Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

710.66%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-97.62%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

75.39%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ